Study on the sensitivity test of carcinostatic agents by acid phosphatase activity.
D000135:Acid Phosphatase / Q000378:metabolism*; D000328:Adult; D000368:Aged; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002865:Chromomycins / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008466:Mechlorethamine / Q000031:analogs & derivatives / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D008875:Middle Aged; D008937:Mitomycins / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000201:enzymology; D051381:Rats; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000201:enzymology; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D002865:Chromomycins; D008937:Mitomycins; D008466:Mechlorethamine; D014750:Vincristine; D003520:Cyclophosphamide; D000135:Acid Phosphatase; D005472:Fluorouracil; D008727:Methotrexate